Azitra Inc
AZTRHealthcare·Biotechnology·USA·Nano·AMEX·Nov 11 • 8:09 AM ET
0.60000.0000 (0.00%)
2026-11-11 14:25 CET
Market cap
3.64 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-12.27 USD m
Free cash flow, TTM
-11.17 USD m
EPS diluted, TTM
-13.06
P/E
-
Price
AZTR against its 20, 50 and 200-day averages2050200earnings
94.5% under 10.90 on 20 Oct 2025. Last 15 sessions, 311.2% high to low
Profile
AZTR52-week range, 2% of the way up
0.524.30
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.
| Employees | 13 |
|---|---|
| IPO | Jun 16, 2023 |
| Beta | -0.86 |
| ATR, 14d | 0.18 |
| Rel volume | 0.04 |
| Short float | 5.41% |
| Inst own | 32.13% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 3.64M |
| Enterprise Value | -2.68M |
| Income | -12.27M |
| Sales | 0.00M |
| Book/sh | 1.21 |
| Cash/sh | 1.11 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 13 |
| IPO | Jun 16, 2023 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | - |
| P/B | 0.50 |
| P/C | 0.54 |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | - |
| Quick Ratio | 4.86 |
| Current Ratio | 4.86 |
| Debt/Eq | 0.06 |
| LT Debt/Eq | 0.01 |
| Option/Short | No / Yes |
Earnings
| EPS (ttm) | -13.06 |
|---|---|
| EPS next Y | -0.64 |
| EPS next Q | -0.25 |
| EPS this Y | 90.89% |
| EPS next Y | 68.78% |
| EPS next 5Y | 69.96% |
| EPS past 3/5Y | 78.38% 67.17% |
| Sales past 3/5Y | - - |
| EPS Y/Y TTM | 78.16% |
| Sales Y/Y TTM | -100.00% |
| EPS Q/Q | 85.32% |
| Sales Q/Q | - |
| Earnings | Aug 12 AMC |
| EPS/Sales Surpr. | -47.83% - |
Ownership
| Insider Own | - |
|---|---|
| Insider Trans | - |
| Inst Own | 32.13% |
| Inst Trans | 39.61% |
| ROA | -190.69% |
| ROE | -256.67% |
| ROIC | -166.18% |
| Gross Margin | - |
| Oper. Margin | - |
| Profit Margin | - |
| SMA20 | -38.19% |
| SMA50 | -56.64% |
| SMA200 | -67.24% |
| Trades | - |
Technical
| Shs Outstand | 6.06M |
|---|---|
| Shs Float | 5.65M |
| Short Float | 5.41% |
| Short Ratio | 0.10 |
| Short Interest | 0.31M |
| 52W High | 4.30 -86.04% |
| 52W Low | 0.52 15.83% |
| Volatility | 11.61% 25.44% |
| ATR (14) | 0.18 |
| RSI (14) | 34.41 |
| Beta | -0.86 |
| Rel Volume | 0.04 |
| Avg Volume | 2.98M |
| Volume | 5,620 |
Performance
| Perf Week | -26.44% |
|---|---|
| Perf Month | -16.08% |
| Perf Quarter | -57.14% |
| Perf Half Y | -72.32% |
| Perf YTD | -77.34% |
| Perf Year | -84.89% |
| Perf 3Y | -99.98% |
| Perf 5Y | - |
| Perf 10Y | - |
| Recom | 1.00 |
| Target Price | 3.00 |
| Prev Close | 0.60 |
| Price | 0.60 |
| Change % | 0.00% |
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-12 | -1.700 | -1.150 | -0.200 | 0.00 | 0.00 | 2 |
| 2026Q3 | - | - | -0.250 | - | - | 0.00 | 1 |
| 2026Q4 | - | - | -0.250 | - | - | 0.00 | 1 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2025FY | -22.500 | -24.800 | -21.500 | 0.00 | 0.00 |
| 2026FY | - | -2.050 | - | - | 0.00 |
| 2027FY | - | -0.640 | - | - | 0.00 |
| 2028FY | - | -0.610 | - | - | 0.00 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | S | 2026-08-13 | 1 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q3 | S | 2026-05-21 | 1 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2026Q3 | R | 2026-08-13 | 1 | 0 | 0 | -0.20 | -0.20 | -0.20 |
| 2026Q3 | R | 2026-06-08 | 1 | 0 | 0 | -0.20 | -0.20 | -0.20 |
| 2026Q3 | R | 2026-05-13 | 1 | 1 | 0 | -0.20 | -0.20 | -0.20 |
| 2026Q3 | R | 2026-03-25 | 1 | 1 | 0 | -0.20 | -0.20 | -0.20 |
| 2026Q3 | R | 2026-03-04 | 1 | 1 | 0 | -2.70 | -2.70 | -2.70 |
| 2026Q3 | R | 2026-03-02 | 1 | 0 | 0 | -3.50 | -3.50 | -3.50 |
| 2026Q3 | R | 2026-02-14 | 1 | 0 | 0 | -3.50 | -3.50 | -3.50 |
| 2026Q3 | R | 2025-12-01 | 1 | 1 | 0 | -3.50 | -3.50 | -3.50 |
| 2026Q3 | R | 2025-11-13 | 1 | 0 | 0 | -7.60 | -7.60 | -7.60 |
| 2026Q3 | R | 2025-11-11 | 1 | 0 | 0 | -7.60 | -7.60 | -7.60 |
| 2026Q3 | R | 2025-11-10 | 1 | 0 | 0 | -7.60 | -7.60 | -7.60 |
| 2026Q3 | R | 2025-11-09 | 1 | 0 | 0 | -7.60 | -7.60 | -7.60 |
Estimate history
| EPS, annual | -1935.543 | -2223.294 | -2087.43 | -157.811 | -22.479 | -13.0585 | |||
|---|---|---|---|---|---|---|---|---|---|
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | |||
| EPS, quarterly | -182.557 | -11.563 | -20.9 | -15.515 | -11.819 | -6.714 | -2.08 | -2.531 | -1.735 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
| Sales, annual | 0.11 | 0.284 | 0.686 | 0.008 | 0 | 0 | |||
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | |||
| Sales, quarterly | 0.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
| Shares, annual | 0.006 | 0.006 | 0.006 | 0.115 | 1.074 | 6.06 | |||
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ | |||
| Shares, quarterly | 0.014 | 0.115 | 0.115 | 0.225 | 0.27 | 0.56 | 1.074 | 1.619 | 6.06 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.01 | 0.69 | 0.28 | 0.11 |
| Cost of Goods Sold Incl. D&A | 0.46 | 0.45 | 0.45 | 0.43 | 0.41 | 0.08 |
| Gross Profit | -0.46 | -0.45 | -0.44 | 0.26 | -0.12 | 0.03 |
| Selling, General and Administrative Excl. Other | 11.89 | 10.51 | 10.10 | 7.53 | 9.33 | 9.25 |
| Research and Development | 5.10 | 4.84 | 4.72 | 3.81 | 6.10 | 5.38 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -12.35 | -10.97 | -10.54 | -7.27 | -9.45 | -9.22 |
| Interest Expense | 0.01 | 0.01 | 0.01 | 0.17 | 0.25 | 0.07 |
| Unusual Expense | -0.00 | -0.00 | -1.46 | 3.93 | 1.02 | -0.23 |
| Net Income Before Taxes | -12.26 | -10.95 | -8.96 | -11.27 | -10.68 | -8.94 |
| Income Taxes | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 |
| Consolidated Net Income | -12.27 | -10.96 | -8.97 | -11.28 | -10.68 | -8.94 |
| Net Income From Continuing Operations | -12.27 | -10.96 | -8.97 | -11.28 | -10.68 | -8.94 |
| Net Income | -12.27 | -10.96 | -8.97 | -12.64 | -13.45 | -11.71 |
| EPS (Recurring) | -6.36 | -22.48 | -175.78 | -1,633.64 | -2,105.24 | -1,962.44 |
| EPS (Basic, Before Extraordinaries) | -13.06 | -22.48 | -157.81 | -2,087.43 | -2,223.29 | -1,935.54 |
| EPS (Diluted) | -13.06 | -22.48 | -157.81 | -2,087.43 | -2,223.29 | -1,935.54 |
| EBITDA | -11.89 | -10.51 | -10.09 | -6.84 | -9.05 | -9.14 |
| Non-Operating Income (Expense) | 0.09 | 0.03 | 0.14 | 0.09 | 0.05 | 0.12 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 0.05 | 0.19 | 0.12 | 0.18 | 0.31 |
| Price To Sales Ratio | - | - | 214.71 | 16.22 | - | - |
| Gross Margin | - | - | -5,876.47 | 37.97 | -42.95 | 22.93 |
| Operating Margin | - | - | -140,564.63 | -1,059.04 | -3,328.73 | -8,383.14 |
| Net Margin | - | - | -119,566.56 | -1,842.44 | -4,735.69 | -10,644.24 |
| Shares Outstanding | 6.06 | 1.07 | 0.11 | 0.01 | 0.01 | 0.01 |
| Market Capitalization | 3.64 | 3.64 | 3.24 | 11.13 | 11.13 | - |
Income statement, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.10 |
| Gross Profit | -0.11 | -0.12 | -0.11 | -0.11 | -0.11 | -0.12 | -0.12 | -0.10 |
| Selling, General and Administrative Excl. Other | 3.31 | 3.82 | 2.11 | 2.66 | 2.76 | 2.98 | 2.32 | 2.83 |
| Research and Development | 1.35 | 1.56 | 1.00 | 1.18 | 1.40 | 1.25 | 1.12 | 1.02 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.42 | -3.93 | -2.23 | -2.77 | -2.87 | -3.10 | -2.43 | -2.93 |
| Interest Expense | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -1.87 |
| Net Income Before Taxes | -3.35 | -3.93 | -2.23 | -2.76 | -2.89 | -3.07 | -2.38 | -1.01 |
| Income Taxes | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Consolidated Net Income | -3.35 | -3.93 | -2.23 | -2.76 | -2.89 | -3.07 | -2.39 | -1.01 |
| Net Income From Continuing Operations | -3.35 | -3.93 | -2.23 | -2.76 | -2.89 | -3.07 | -2.39 | -1.01 |
| Net Income | -3.35 | -3.93 | -2.23 | -2.76 | -2.89 | -3.07 | -2.39 | -1.01 |
| EPS (Recurring) | -1.73 | -2.53 | -2.08 | -6.71 | -11.82 | -15.52 | -20.90 | -26.55 |
| EPS (Basic, Before Extraordinaries) | -1.73 | -2.53 | -2.08 | -6.71 | -11.82 | -15.51 | -20.90 | -11.56 |
| EPS (Diluted) | -1.73 | -2.53 | -2.08 | -6.71 | -11.82 | -15.51 | -20.90 | -11.56 |
| EBITDA | -3.31 | -3.82 | -2.11 | -2.66 | -2.76 | -2.98 | -2.32 | -2.83 |
| Non-Operating Income (Expense) | 0.07 | 0.01 | 0.01 | 0.00 | -0.02 | 0.03 | 0.06 | 0.05 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.01 | 0.01 | - | 0.00 | 0.02 | 0.03 | 0.03 | 0.14 |
| Price To Sales Ratio | - | - | - | - | - | 532.13 | 432.65 | 32.38 |
| Shares Outstanding | 6.06 | 1.62 | 1.07 | 0.56 | 0.27 | 0.22 | 0.11 | 0.11 |
| Market Capitalization | 3.64 | 3.79 | 2.84 | 3.92 | 4.70 | 4.54 | 3.24 | 4.14 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|
| Cash & Short Term Investments | 2.07 | 4.55 | 1.80 | 3.49 | 8.04 |
| Short Term Receivables | 0.14 | 0.10 | 0.22 | 0.27 | 0.33 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.81 | 0.57 | 0.45 | 0.16 | 0.11 |
| Total Current Assets | 3.02 | 5.22 | 2.47 | 3.92 | 8.49 |
| Net Property, Plant & Equipment | 0.96 | 1.21 | 1.58 | 1.96 | 0.95 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.32 | 0.25 | 0.21 | 1.02 | 0.72 |
| Other Assets | 0.73 | 0.68 | 0.86 | 0.26 | 0.05 |
| Total Assets | 5.03 | 7.36 | 5.12 | 7.17 | 10.20 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.46 | 0.27 | 0.32 | 0.29 | 0.00 |
| Accounts Payable | 0.40 | 0.49 | 0.90 | 0.78 | 0.72 |
| Income Tax Payable | 0.01 | 0.01 | - | 0.00 | 0.00 |
| Other Current Liabilities | 0.20 | 0.60 | 0.38 | 1.15 | 0.49 |
| Total Current Liabilities | 1.07 | 1.38 | 1.60 | 2.22 | 1.21 |
| Long Term Debt | 0.16 | 0.28 | 0.56 | 41.14 | 34.69 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.04 | 0.07 | 0.07 |
| Total Liabilities | 1.22 | 1.66 | 2.20 | 43.43 | 35.97 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 3.80 | 5.70 | 2.91 | -36.26 | -25.77 |
| Total Shareholders Equity | 3.80 | 5.70 | 2.91 | -36.26 | -25.77 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 3.80 | 5.70 | 2.91 | -36.26 | -25.77 |
| Total Liabilities & Stockholders Equity | 5.03 | 7.36 | 5.12 | 7.17 | 10.20 |
| Book Value Per Share | 3.54 | 49.76 | 481.12 | -5,994.13 | -4,259.32 |
| Tangible Book Value Per Share | 3.24 | 47.61 | 446.30 | -6,162.81 | -4,377.96 |
| Full-Time Employees | 13 | 12 | 10 | 10 | - |
| Price to Book Ratio | 0.50 | 0.57 | 2.09 | 2.09 | - |
| Return on Assets | -176.93 | -143.78 | -183.73 | -122.98 | - |
| Return on Equity | -230.65 | -208.27 | - | - | - |
| Return on Invested Capital | -276.83 | -149.89 | -324.54 | -219.08 | -100.21 |
| Quick Ratio | 2.83 | 3.80 | 1.54 | 1.76 | 7.02 |
| Current Ratio | 2.83 | 3.80 | 1.54 | 1.76 | 7.02 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|---|
| Net Income | -12.27 | -10.96 | -8.97 | -11.28 | -10.68 | -8.94 |
| Depreciation | 0.46 | 0.45 | 0.45 | 0.43 | 0.41 | 0.08 |
| Other Funds (Non Cash) | 0.66 | 0.08 | -1.26 | 4.25 | 1.61 | 0.14 |
| Funds from Operations | -11.16 | -10.43 | -9.78 | -6.61 | -8.66 | -8.71 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.05 | -0.80 | -0.44 | -0.75 | 0.31 | 0.65 |
| Income Taxes Payable | - | - | - | - | 0.00 | -0.01 |
| Cash from Operating Activities | -11.11 | -11.22 | -10.22 | -7.36 | -8.35 | -8.07 |
| Capital Expenditures | -0.28 | -0.19 | -0.38 | -0.32 | -0.34 | -0.65 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.28 | -0.18 | -0.38 | -0.32 | -0.34 | -0.65 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 17.38 | 9.03 | 13.37 | 5.99 | 0.00 | 0.01 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 17.38 | 9.03 | 13.37 | 5.99 | 0.00 | 0.01 |
| Proceedsfrom Stock Options | 17.18 | 9.03 | 13.35 | 5.99 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.31 | -0.11 | -0.01 | -0.01 | 4.13 | 0.98 |
| Change in Long Term Debt | -0.02 | -0.02 | -0.01 | -0.01 | 4.13 | 0.98 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 4.13 | 0.98 |
| Reduction of Long Term Debt | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 17.07 | 8.92 | 13.36 | 5.98 | 4.13 | 0.99 |
| Net Change in Cash | 5.68 | -2.49 | 2.76 | -1.70 | -4.55 | -7.73 |
| Free Cash Flow | -11.17 | -11.25 | -10.23 | -7.39 | -8.38 | -8.51 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | - | - | - |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 6.73 | 10.05 | 2.07 | 1.40 | 1.05 | 3.21 |
| Short Term Receivables | 0.14 | 0.15 | 0.14 | 0.01 | 0.08 | 0.10 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.57 | 0.55 | 0.81 | 0.82 | 0.68 | 0.56 |
| Total Current Assets | 7.44 | 10.76 | 3.02 | 2.23 | 1.80 | 3.87 |
| Net Property, Plant & Equipment | 0.94 | 0.86 | 0.96 | 1.07 | 1.17 | 1.09 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.33 | 0.33 | 0.32 | 0.27 | 0.26 | 0.24 |
| Other Assets | 0.20 | 0.17 | 0.73 | 0.73 | 0.73 | 0.70 |
| Total Assets | 8.92 | 12.13 | 5.03 | 4.30 | 3.96 | 5.91 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.36 | 0.35 | 0.46 | 0.58 | 0.30 | 0.25 |
| Accounts Payable | 0.50 | 0.93 | 0.40 | 0.72 | 0.64 | 0.56 |
| Income Tax Payable | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.67 | 0.27 | 0.20 | 0.51 | 0.51 | 0.47 |
| Total Current Liabilities | 1.53 | 1.55 | 1.07 | 1.81 | 1.45 | 1.28 |
| Long Term Debt | 0.05 | 0.10 | 0.16 | 0.21 | 0.27 | 0.22 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 5E-05 | 0.00 | 0.00 |
| Total Liabilities | 1.58 | 1.65 | 1.22 | 2.02 | 1.73 | 1.50 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 7.33 | 10.48 | 3.80 | 2.28 | 2.23 | 4.41 |
| Total Shareholders Equity | 7.33 | 10.48 | 3.80 | 2.28 | 2.23 | 4.41 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 7.33 | 10.48 | 3.80 | 2.28 | 2.23 | 4.41 |
| Total Liabilities & Stockholders Equity | 8.92 | 12.13 | 5.03 | 4.30 | 3.96 | 5.91 |
| Book Value Per Share | 1.21 | 6.47 | 3.54 | 4.07 | 8.26 | 19.60 |
| Tangible Book Value Per Share | 1.16 | 6.27 | 3.24 | 3.58 | 7.30 | 18.51 |
| Full-Time Employees | - | - | 13 | - | - | - |
| Price to Book Ratio | 0.50 | 0.36 | 0.75 | 1.72 | 2.11 | 1.03 |
| Return on Assets | -190.69 | -131.02 | -176.93 | -157.91 | -238.82 | -152.02 |
| Return on Equity | -256.67 | -158.71 | -230.65 | -215.04 | -473.31 | -208.50 |
| Return on Invested Capital | -45.33 | -37.13 | -56.44 | -110.84 | -115.40 | -66.31 |
| Quick Ratio | 4.86 | 6.94 | 2.83 | 1.23 | 1.24 | 3.02 |
| Current Ratio | 4.86 | 6.94 | 2.83 | 1.23 | 1.24 | 3.02 |
Cash flow, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Net Income | -3.35 | -3.93 | -2.23 | -2.76 | -2.89 | -3.07 |
| Depreciation | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 | 0.12 |
| Other Funds (Non Cash) | 0.01 | 0.63 | 0.01 | 0.01 | 0.02 | 0.03 |
| Funds from Operations | -3.23 | -3.18 | -2.11 | -2.64 | -2.75 | -2.92 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.06 | 0.70 | -0.79 | 0.20 | -0.06 | -0.15 |
| Cash from Operating Activities | -3.29 | -2.48 | -2.89 | -2.44 | -2.82 | -3.07 |
| Capital Expenditures | -0.12 | -0.04 | -0.08 | -0.04 | -0.04 | -0.02 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.12 | -0.04 | -0.08 | -0.04 | -0.04 | -0.02 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.19 | 10.60 | 3.74 | 2.85 | 0.69 | 1.75 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.19 | 10.60 | 3.74 | 2.85 | 0.69 | 1.75 |
| Proceedsfrom Stock Options | -0.01 | 10.60 | 3.74 | 2.85 | 0.69 | 1.75 |
| Issuance or Reduction of Debt, Net | -0.10 | -0.10 | -0.10 | -0.00 | -0.00 | -0.00 |
| Change in Long Term Debt | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 0.09 | 10.50 | 3.64 | 2.84 | 0.69 | 1.75 |
| Net Change in Cash | -3.32 | 7.98 | 0.67 | 0.36 | -2.16 | -1.35 |
| Free Cash Flow | -3.33 | -2.49 | -2.90 | -2.45 | -2.83 | -3.07 |
Revenue breakdown
| Pharmaceutical Preparations | 2024: 7.50K |
|---|---|
| United States | 2024: 7.50K |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 5.41% | 0.3M | 5.7M | 2.98M |
Option chain
expiry 2026-11-11| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-10 | 8-K | Current report | 2026-11-10 | SEC |
| 2026-10-29 | 8-K | Current report | 2026-10-29 | SEC |
| 2026-10-26 | 8-K | Current report | 2026-10-26 | SEC |
| 2026-10-22 | 8-K | Current report | 2026-10-22 | SEC |
| 2026-10-01 | 8-K | Current report | 2026-10-01 | SEC |
| 2026-09-28 | 8-K | Current report | 2026-09-28 | SEC |
| 2026-09-28 | 424B5 | SEC | ||
| 2026-09-08 | 8-K | Current report | 2026-09-08 | SEC |
| 2026-08-21 | 8-K | Current report | 2026-08-21 | SEC |
| 2026-08-14 | SCHEDULE 13G | SEC | ||
| 2026-08-14 | SCHEDULE 13G | SEC | ||
| 2026-08-12 | 8-K | Current report | 2026-08-12 | SEC |
| 2026-08-12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-07-15 | 8-K | Current report | 2026-07-15 | SEC |
| 2026-06-25 | SCHEDULE 13G | SEC | ||
| 2026-06-24 | SCHEDULE 13D | SEC | ||
| 2026-06-22 | SCHEDULE 13G | SEC | ||
| 2026-06-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-16 | SEC |
| 2026-06-17 | 8-K | Current report | 2026-06-17 | SEC |
| 2026-06-16 | 8-K | Current report | 2026-06-15 | SEC |
| 2026-06-04 | DEFA14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-06-04 | 8-K | Current report | 2026-06-04 | SEC |
| 2026-06-02 | EFFECT | Effectiveness filing by commission order | SEC | |
| 2026-05-29 | CORRESP | SEC | ||
| 2026-05-27 | DEFA14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-05-27 | 8-K | Current report | 2026-05-27 | SEC |
| 2026-05-27 | UPLOAD | Upload Submission | SEC | |
| 2026-05-21 | S-1 | General form of registration statement for all companies including face-amount certificate companies | SEC | |
| 2026-05-13 | 8-K | Current report | 2026-05-13 | SEC |
| 2026-05-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Dauntless Investment Group, LLC | 69.74% |
| Stonepine Capital Management, LLC | 32.64% |
| Nantahala Capital Management, LLC | 27.34% |
| JANE STREET GROUP, LLC | 1.53% |
| CITADEL ADVISORS LLC | 0.53% |
| Virtu Financial LLC | 0.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.16% |
| StoneX Group Inc. | 0.14% |
| Tower Research Capital LLC | 0.12% |
| Corient Private Wealth LP | 0.09% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Extended Market Index Fund | 0.16% |
| Blackstone Alternative Multi-Strategy Fund | 0.00% |
OakChart. AZTR. Cached 15 minutes.
Some panels did not load: ratings, insider, news.